Joseph Campbell, MD
Interventional Cardiology · Columbus, OHNPI 1790006039
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Inari Medical, Inc. at 39.3% of the total. Reporting peaked in 2024 at $48,651 and has fallen 61.4% since, to $18,803 in 2025. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 264 payments — averaging $431.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$45K
- Abbott$25K
- Medtronic$12K
- Surmodics, Inc.$11K
- Stryker$11K
- Angiodynamics, Inc.$4K
- plus $6K from 18 others
Across 42 payments — averaging $3389.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$52K
- Medtronic$48K
- AstraZeneca$42K
What the payments were for
- Consulting fees$53,25947%
- Speaking & faculty fees$35,67531%
- Travel & lodging$14,83913%
- Food & beverage$10,2619%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 60 | $44,790 |
| Abbott | 61 | $25,020 |
| Medtronic(2 entities) | 52 | $11,999 |
| Surmodics, Inc. | 13 | $11,483 |
| Stryker | 6 | $10,805 |
| Angiodynamics, Inc. | 5 | $3,959 |
| Cardiovascular Systems Inc. | 27 | $1,592 |
| Penumbra, Inc. | 7 | $816 |
| Boston Scientific | 10 | $791 |
| Endovascular Engineering Inc. | 1 | $750 |
| Endologix LLC | 4 | $373 |
| Argon Medical Devices, Inc. | 2 | $336 |
| Bard Peripheral Vascular, Inc. | 1 | $214 |
| W. L. Gore & Associates, Inc. | 1 | $195 |
| Centerline Biomedical Inc. | 1 | $173 |
| Inquis Medical, Inc. | 2 | $161 |
| Shockwave Medical, Inc | 2 | $148 |
| Abiomed | 1 | $128 |
| Avinger Inc. | 1 | $100 |
| Siemens Medical Solutions USA, Inc. | 1 | $89 |
| Novo Nordisk | 2 | $37 |
| Asahi Intecc USA, Inc. | 2 | $30 |
| Amgen | 1 | $23 |
| Getinge USA Sales, LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$54,823
- CT THROMBECTOMY SYSTEM KIT$54,823
- Pounce Thrombectomy$8,295
- Pounce Venous Thrombectomy System$8,295
- Pounce Thrombectomy System$8,295
- Pounce LP Thrombectomy$8,295
- Auryon Laser System 100-120 Vac$3,465
- Pounce Thrombectomy System Retrospective Registry$3,150
- TENDYNE$1,695
- Peripheral Orbital Atherectomy System$1,235
- HawkOne$1,150
- Omnilink Elite vascular stent system$1,141
- XIENCE SIERRA$1,000
- ESPRIT$900
- Helo Thrombectomy System$750
- Indigo System$711
- IN.PACT Admiral$340
- AlphaVac$244
- ClosureRFS$213
- OPTION$211
How this compares
$114,034 in reported general payments places this provider in the 90th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 123 | $135,245 |
| XareltoRivaroxaban | 31 | $34,538 |
| ClopidogrelClopidogrel Bisulfate | 120 | $1,019 |
| Cilostazol | 19 | $581 |
| Atorvastatin Calcium | 67 | $370 |
| Carvedilol | 17 | $179 |
| Rosuvastatin Calcium | 25 | $179 |
| Losartan Potassium | 27 | $163 |
| Amlodipine Besylate | 56 | $143 |
| Metoprolol Succinate | 22 | $136 |
| Lisinopril | 14 | $59 |
| Metoprolol Tartrate | 24 | $37 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Columbus
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- Michael JollyColumbus$281K
- Timothy SmithColumbus$149K
- Christopher HuffColumbus$119K
- Aref AmroColumbus$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.